Frequencies of the clinical types of Shimoyama classification in each eruption type and T stage
| . | Acute type . | Lymphoma type . | Chronic type . | Smoldering type . | P . |
|---|---|---|---|---|---|
| Eruption type | .015 | ||||
| Patch type | 0 | 0 | 1 (12.8%) | 7 (87.2%) | |
| Plaque type | 9 (28.1%) | 4 (12.5%) | 0 | 19 (59.4%) | |
| Multipapular type | 10 (43.5%) | 2 (8.7%) | 0 | 11 (47.8%) | |
| Nodulotumoral type | 14 (30.4%) | 10 (21.7%) | 5 (10.9%) | 17 (37.0%) | |
| Erythrodermic type | 5 (100%) | 0 | 0 | 0 | |
| Purpuric type | 2 (40.0%) | 1 (20.0%) | 0 | 2 (40.0%) | |
| T stage | .004 | ||||
| T1 | 2 (10.5%) | 1 (5.3%) | 0 | 16 (84.2%) | |
| T2 | 7 (33.3%) | 3 (14.3%) | 1 (4.8%) | 10 (47.6%) | |
| T3 | 14 (30.4%) | 10 (21.7%) | 5 (10.9%) | 17 (37.0%) | |
| T4 | 5 (100%) | 0 | 0 | 0 |
| . | Acute type . | Lymphoma type . | Chronic type . | Smoldering type . | P . |
|---|---|---|---|---|---|
| Eruption type | .015 | ||||
| Patch type | 0 | 0 | 1 (12.8%) | 7 (87.2%) | |
| Plaque type | 9 (28.1%) | 4 (12.5%) | 0 | 19 (59.4%) | |
| Multipapular type | 10 (43.5%) | 2 (8.7%) | 0 | 11 (47.8%) | |
| Nodulotumoral type | 14 (30.4%) | 10 (21.7%) | 5 (10.9%) | 17 (37.0%) | |
| Erythrodermic type | 5 (100%) | 0 | 0 | 0 | |
| Purpuric type | 2 (40.0%) | 1 (20.0%) | 0 | 2 (40.0%) | |
| T stage | .004 | ||||
| T1 | 2 (10.5%) | 1 (5.3%) | 0 | 16 (84.2%) | |
| T2 | 7 (33.3%) | 3 (14.3%) | 1 (4.8%) | 10 (47.6%) | |
| T3 | 14 (30.4%) | 10 (21.7%) | 5 (10.9%) | 17 (37.0%) | |
| T4 | 5 (100%) | 0 | 0 | 0 |